Millions more Americans now eligible for statins. What new cholesterol guidelines mean

Key Points:

• Updated 2026 cholesterol guidelines may increase statin eligibility by 21.5 million U.S. adults, bringing the total to about 87.5 million, or over half of adults aged 30 to 79, according to a JAMA study.
• The new guidelines expand risk assessment to adults aged 30-79, lower cardiovascular risk thresholds, emphasize certain medical conditions like chronic kidney disease and HIV, and incorporate long-term (30-year) risk estimates.
• Statin eligibility indicates consideration, not automatic prescription; decisions should be personalized based on age, medical history, and risk factors, with discussions between patients and healthcare providers.
• Statins are generally well-tolerated and reduce heart attack and stroke risk, though they may slightly increase diabetes risk; lifestyle changes remain essential for all individuals to manage cardiovascular risk.
• The guidelines aim to promote earlier cholesterol management tailored to both short- and long-term risk, encouraging preventive conversations rather than immediate medication for all newly eligible adults.